Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | THRB | P10828 | 1/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.62 |
| ▸ | CD69 | Q07108 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.49 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.49 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7155546 | 0.88 | ALDH1A1 (0.65) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL7155543 | 0.88 | ALDH1A1 (0.65) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| Bromide SCHEMBL28686876 | 0.87 | ALDH1A1 (0.64) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL24943853 | 0.86 | ALDH1A1 (0.67) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL22596723 | 0.86 | ALDH1A1 (0.67) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL21415435 | 0.86 | ALDH1A1 (0.67) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL24223153 | 0.86 | ALDH1A1 (0.67) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL23705217 | 0.86 | ALDH1A1 (0.67) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL23705274 | 0.86 | ALDH1A1 (0.67) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL24996997 | 0.86 | ALDH1A1 (0.67) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023015223-A9 | COMPOSITIONS AND METHODS FOR TARGETED RNA DELIVERY | VERVE THERAPEUTICS, INC. (US) | 2023-04-06 | — | — | WO | disclosed |
| WO-2023015223-A2 | COMPOSITIONS AND METHODS FOR TARGETED RNA DELIVERY | VERVE THERAPEUTICS, INC. (US) | 2023-02-09 | — | — | WO | disclosed |